Filing Flows › Relay Therapeutics (RLAY) › Q1 2026 › vs Q1 2025
Relay Therapeutics (RLAY) Q1 2026 vs Q1 2025 (year over year)
Relay Therapeutics's revenue fell $4.7M (-61%) from $7.7M in Q1 2025 to $3.0M in Q1 2026.
Relay Therapeutics, Q1 2026: revenue $3.0M (-61% year over year), net loss $73.3M, operating cash flow −$51.1M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $3.0M | $7.7M | −$4.7M | -61% |
| Other income, net | $5.3M | $7.8M | −$2.5M | -32% |
| Net loss | $73.3M | $77.1M | −$3.8M | -5% |
| Costs & expenses | $81.6M | $92.5M | −$11.0M | -12% |
| Operating costs | $81.6M | $92.5M | −$11.0M | -12% |
| Research & development | $70.6M | $73.8M | −$3.2M | -4% |
| General & admin | $11.0M | $18.7M | −$7.7M | -41% |
| Operating cash sources | $73.3M | $77.1M | −$3.8M | -5% |
| Depreciation | $504K | $1.2M | −$704K | -58% |
| Share-based compensation | $10.5M | $19.3M | −$8.8M | -45% |
| Working capital & other | $11.1M | −$16.7M | $27.8M | — |
| Cash used in operations | $51.1M | $73.2M | −$22.1M | -30% |
| Net loss absorbed | $73.3M | $77.1M | −$3.8M | -5% |
Questions
How much did Relay Therapeutics's revenue grow year over year in Q1 2026?
Relay Therapeutics's revenue fell $4.7M (-61%) from $7.7M in Q1 2025 to $3.0M in Q1 2026.